Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408141 · ClinicalTrials.gov registry record
MiniMed Fit Payload Wear Study
A clinical trial of Diabetes (Insulin-requiring, Type 1 or Type 2), sponsored by Medtronic Diabetes.
- Recruiting
- Registry status
- 175
- Enrollment target
- 4
- Study locations
NCT07408141: Recruiting study of Diabetes (Insulin-requiring, Type 1 or Type 2), sponsored by Medtronic Diabetes.
NCT07408141 is a study of Diabetes (Insulin-requiring, Type 1 or Type 2) that is actively recruiting participants, run by Medtronic Diabetes. The registered enrollment target is 175 participants. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07408141, a study of Diabetes (Insulin-requiring, Type 1 or Type 2), is actively recruiting participants, sponsored by Medtronic Diabetes.
- RECRUITING
- Registry status
- 175 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to assess success/failure of the MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump.
Primary Outcome
The number of MiniMed Fit Payload that meet the success criteria divided by the total number of MiniMed Fit Payload devices applied at the end of Day 5.
Conditions Studied
Interventions
- DEVICE MiniMed Fit Payload adhesive components
Study Locations (4)
California
- ProSciento - Chula Vista
- Headlands Research California LLC - Escondido
New York
- NYC Research Inc - Long Island City
Washington
- Rainer Clinical Research Center - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2026-02-19 |
| Est. Completion | 2026-05 |
What NCT07408141 shows while recruiting
NCT07408141 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Diabetes (Insulin-requiring, Type 1 or Type 2) appearing as the primary indexed condition, and to 1 intervention - of which MiniMed Fit Payload adhesive components is the first listed.
NCT07408141 reports a single indexed study location in California, New York, Washington.
Frequently Asked Questions
What is clinical trial NCT07408141 about?
NCT07408141 is a clinical study titled "MiniMed Fit Payload Wear Study". The purpose of this study is to assess success/failure of the MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump.
What is the current status of trial NCT07408141?
This trial is currently recruiting. The enrollment target is 175 participants. The study started on 2026-02-19. Estimated completion is 2026-05.
What conditions does trial NCT07408141 study?
This clinical trial studies the following conditions: Diabetes (Insulin-requiring, Type 1 or Type 2).
What interventions are being tested in trial NCT07408141?
The interventions under investigation include: MiniMed Fit Payload adhesive components (DEVICE).
Who is sponsoring clinical trial NCT07408141?
This trial is sponsored by Medtronic Diabetes, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07408141 being conducted?
This trial has 4 study locations across California, New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI